Institutional investors purchased a net $918.7 thousand shares of OXGN during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 11.08% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GO ETF SOLUTIONS LLP Bought 360.5 Thousand shares of OXiGENE Inc